Company · Montreal, Quebec, Canada
Erfa Canada 2012 Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 18
- 0 authorized now
- Natural health products
- 6
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 10
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ATARAX CAP 10MGStatus since Sep 2005 | 00024376 | Cancelled Post Market | |
| ATARAX CAP 25MGStatus since Sep 2005 | 00024384 | Cancelled Post Market | |
| ATARAX CAP 50MGStatus since Sep 2005 | 00024392 | Cancelled Post Market | |
| ATARAX IM SOL 50MG/MLStatus since Aug 2005 | 00024589 | Cancelled Post Market | |
| CELONTIN CAP 300MGStatus since Jun 2015 | 00022802 | Cancelled Post Market | |
| CHOLEDYL SA TABLETS 400MGStatus since Jul 2005 | 00503436 | Cancelled Post Market | |
| CHOLEDYL SA TABLETS 600MGStatus since Jul 2005 | 00536709 | Cancelled Post Market | |
| ERFA THYROIDStatus since Jul 2024 | 02499401 | Cancelled Pre Market | |
| ERFA THYROIDStatus since Jul 2024 | 02499428 | Cancelled Pre Market | |
| ERFA THYROIDStatus since Jul 2024 | 02499436 | Cancelled Pre Market | |
| ERGODRYL CAPStatus since Jul 2013 | 00156086 | Cancelled Post Market | |
| NAVANE CAP 2MGStatus since Jun 2015 | 00024430 | Cancelled Post Market | |
| NAVANE CAPSULES 10MGStatus since Jun 2015 | 00024457 | Cancelled Post Market | |
| PHENOBARBITAL TAB 15MGStatus since Aug 2005 | 00023795 | Cancelled Post Market | |
| PHENOBARBITAL TAB 30MGStatus since Aug 2005 | 00023809 | Cancelled Post Market | |
| PHENOBARBITAL TAB 60MGStatus since Aug 2005 | 00023817 | Cancelled Post Market | |
| PROCAN SRStatus since Jun 2015 | 00638676 | Cancelled Post Market | |
| PROCAN SRStatus since Jun 2015 | 00638684 | Cancelled Post Market |
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| LactigelLicensed May 2016 | 80069410 | Discontinued | |
| Erfa HQ 4% GelLicensed Apr 2016 | 80068828 | Discontinued | |
| MorphélinLicensed May 2014 | 80051235 | Discontinued | |
| Sinomarin Isotonic Sea Water Nasal SprayLicensed Feb 2012 | 80029886 | Discontinued | |
| Sinomarin Isotonic Sea Water Nasal SprayLicensed Feb 2012 | 80029885 | Discontinued | |
| Sinomarin Hypertonic Sea Water Nasal SprayLicensed Feb 2011 | 80023736 | Discontinued |
Notices of Compliance
Newest first.
- LITHANEJune 8, 2022 · NOC 28347 · Supplement to a New Drug Submission (SNDS)
- ATARAX SYRUP 2MG/MLJune 1, 2022 · NOC 28297 · Supplement to a New Drug Submission (SNDS)
- KETALAROctober 8, 2020 · NOC 24399 · Supplement to a New Drug Submission (SNDS)
- CERUBIDINEAugust 25, 2020 · NOC 24120 · Supplement to a New Drug Submission (SNDS)
- ERFA-AMIKACINJune 3, 2019 · NOC 22230 · Abbreviated New Drug Submission (ANDS)
- ERFA-TRANEXAMICSeptember 6, 2016 · NOC 18450 · Abbreviated New Drug Submission (ANDS)
- ATARAX SYRUPMay 11, 2016 · NOC 18132 · Supplement to a New Drug Submission (SNDS)
- NARDILDecember 14, 2015 · NOC 17560 · Supplement to a New Drug Submission (SNDS)
- KETALARSeptember 11, 2015 · NOC 17269 · Supplement to a New Drug Submission (SNDS)
- CEREBYXAugust 21, 2013 · NOC 14674 · Supplement to a New Drug Submission (SNDS)
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- ATARAX (hydroxyzine) - Risk of QT Prolongation and Torsade de PointesJune 6, 2016 · Drugs